Daré Bioscience, Inc. (DARE): Operating Sales Margin

Daré Bioscience (DARE) - corporate logo

Dare Bioscience, Inc. (DARE) generates revenue through the sale of women's health products and royalties. The GURU.Markets portal features a chart where the operating margin reflects a turning point due to the lack of proprietary manufacturing facilities and total reliance on third-party contractors. The modest impact of the first gel's sales defines the current trend, and the latest parameter is -746.10.

DARE: darebioscience.com Operating Profitability 07/04/2022 - 11/19/2026

Metric breakdowns and analytics for darebioscience.com (DARE)

- share price and consensus valuation forecast:
Initial company analysis:Daré Bioscience, Inc., DARE
Core merchandise of Dare Bioscience, Inc.

For the biopharmaceutical business of Dare Bioscience, Inc. (DARE), the average monthly operating margin serves as an indicator of R&D cost management efficiency in the absence of capital expenditures in manufacturing. This metric is calculated as the ratio of operating profit to revenue, demonstrating the share of net income from product sales before accounting for debt load and taxes, which allows for an assessment of scaling potential through partner royalties.